Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.86 -0.08 (-8.41%)
As of: Sep 30, 2026 · 3:59 PM EDT

Bluejay Diagnostics (BJDX) EBITDA Margin (2022)

Updated

Bluejay Diagnostics (BJDX) recorded EBITDA Margin of -3678.60% in FY2022.

Analysis

Bluejay Diagnostics (BJDX) EBITDA Margin (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 21.86%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 41.08%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.55%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 31.93%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.62%
10 Bluejay Diagnostics 1.86 Mn 1.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -779.76%
API Access

Bluejay Diagnostics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BJDX&period=max&api_key=YOUR_API_KEY